Evidence map›Paper›PMID 37013922›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2023

Cusp overlap versus standard three-cusp technique for self-expanding Evolut transcatheter aortic valves.

Hendrik Wienemann, Oliver Maier, Martin Beyer, Max Portratz, Tetsu Tanaka, Victor Mauri, Angela Ernst, Lara Waldschmidt, Elmar Kuhn, Sabine Bleiziffer and 8 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07343674 (PERFECT - Portuguese Evolut Registry Studying the Outcomes of Medtronic Evolut™ FX+ TAVI System by Evaluating an Optimal Care Pathway for TAVI), which is not on this map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07343674 recruitingnot on this mapstarted 2026, after this paper: background citation

PERFECT - Portuguese Evolut Registry Studying the Outcomes of Medtronic Evolut™ FX+ TAVI System by Evaluating an Optimal Care Pathway for TAVI

Typeobservational_patient_registrySponsorPortuguese Association of Interventional CardiologyRan2026 to 2028Enrolled500ConditionsSevere Symptomatic Aortic Stenosis (Defined as New York Heart Association (NYHA) Class ≥ II)
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Conduction Disorders: The Achilles' Heel of TAVR?Journal of clinical medicine · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Cost-effectiveness of TAVI in the United Kingdom: a long-term analysis based on 4-year data from the Evolut Low Risk Trial.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Article
  15. Transcatheter aortic valve implantation in patients with significant septal hypertrophy.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Standardising TAVI procedures: a step towards improved patient care.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Hendrik WienemannClinic III for Internal Medicine, University Hospital Cologne, Cologne, Germany.
Oliver MaierDepartment of Cardiology, Pneumology, and Vascular Medicine, University Hospital Düsseldorf, Düsseldorf, Germany.
Martin BeyerDepartment of Cardiovascular Surgery, University Heart and Vascular Center Hamburg, Hamburg, Germany.
Max PortratzClinic for General and Interventional Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen, Germany.
Tetsu TanakaClinic II for Internal Medicine, University Hospital Bonn, Bonn, Germany.
Victor MauriClinic III for Internal Medicine, University Hospital Cologne, Cologne, Germany.
Angela ErnstInstitute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany.
Lara WaldschmidtDepartment of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
Elmar KuhnDepartment of Cardiovascular Surgery, University Hospital Cologne, Cologne, Germany.
Sabine BleizifferDepartment of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen, Germany.
Nihal WildeClinic II for Internal Medicine, University Hospital Bonn, Bonn, Germany.
Andreas SchaeferDepartment of Cardiovascular Surgery, University Heart and Vascular Center Hamburg, Hamburg, Germany.
Tobias ZeusDepartment of Cardiology, Pneumology, and Vascular Medicine, University Hospital Düsseldorf, Düsseldorf, Germany.
Stephan BaldusClinic III for Internal Medicine, University Hospital Cologne, Cologne, Germany.
Sebastian ZimmerClinic II for Internal Medicine, University Hospital Bonn, Bonn, Germany.
Verena VeulemansDepartment of Cardiology, Pneumology, and Vascular Medicine, University Hospital Düsseldorf, Düsseldorf, Germany.
Tanja Katharina RudolphClinic for General and Interventional Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen, Germany.
Matti AdamClinic III for Internal Medicine, University Hospital Cologne, Cologne, Germany.
University Hospital Cologne · DEUniversität Hamburg · DEHeart and Diabetes Center North Rhine-Westphalia · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReducing rates of permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is important for achieving the best procedural outcomes. The cusp overlap technique (COT) implements procedural steps including an overlap angulation of the right and left coronary cusp to mitigate this complication.

aimsWe investigated the incidence of PPI and complication rates following the COT compared to the standard three-cusp implantation technique (3CT) in an all-comers cohort.

methodsA total of 2,209 patients underwent TAVI with the self-expanding Evolut platform from January 2016 to April 2022 at five sites. Baseline, procedural and in-hospital outcome characteristics were compared for both techniques before and after one-to-one propensity score matching.

resultsA total of 1,151 patients were implanted using the 3CT and 1,058 using the COT. At discharge, the rates of PPI (17.0 vs 12.3%; p=0.002) and moderate/severe paravalvular regurgitation (4.6% vs 2.4%; p=0.006) were significantly reduced with the COT compared with 3CT within the unmatched cohort. Overall procedural success and complication rates were similar; major bleeding was less common in the COT group (7.0% vs 4.6%; p=0.020). These results remained consistent after propensity score matching. In multivariable logistic regression analysis, right bundle branch block (odds ratio [OR] 7.19, 95% confidence interval [CI]: 5.18-10.0; p<0.001) and diabetes mellitus (OR 1.38, 95% CI: 1.05-1.80; p=0.021) emerged as predictors of PPI, whereas the COT (OR 0.63, 95% CI: 0.49-0.82; p<0.001) was protective.

conclusionsThe introduction of the COT was associated with a significant and relevant reduction of PPI and paravalvular regurgitation rates without an increase in complication rates.

Indexed as

Aortic Valve StenosisHeart Valve ProsthesisPacemaker, ArtificialTranscatheter Aortic Valve ReplacementAortic ValveHumansPostoperative ComplicationsProsthesis DesignRisk FactorsTreatment Outcome

Identifiers

PMID37013922
PMCPMC10240731
OpenAlexW4362522008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.